J A Arranz-Caso - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Diagnostic Microbiology and Infectious Disease|November 1, 1996

Penicillin--intermediate-resistant pneumococcal spondylodiscitisJ A Arranz-Caso, N Solé, A Sanchez-Atrio, et al.

Revista Clinica Espanola|April 1, 1996

[Mounier-Kuhn syndrome. 2 representative cases of its clinical spectrum]J A Arranz Caso, J Fernández Francés, D Jiménez Jurado, et al.

Diagnostic Microbiology and Infectious Disease|March 1, 1996

Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazoleJ A Arranz-Caso, V M Lopez-Pizarro, P Gomez-Herruz, et al.

Nephron|January 1, 1995

Severe renal hypouricemia secondary to hyperbilirubinemiaJ A Arranz-Caso, F J Fernández de Paz, V Barrio, et al.

HIV Medicine|September 15, 2005

A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral loadJ A Arranz Caso, J C López, I Santos, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Diagnostic Microbiology and Infectious Disease|November 1, 1996

Penicillin--intermediate-resistant pneumococcal spondylodiscitisJ A Arranz-Caso, N Solé, A Sanchez-Atrio, et al.

Revista Clinica Espanola|April 1, 1996

[Mounier-Kuhn syndrome. 2 representative cases of its clinical spectrum]J A Arranz Caso, J Fernández Francés, D Jiménez Jurado, et al.

Diagnostic Microbiology and Infectious Disease|March 1, 1996

Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazoleJ A Arranz-Caso, V M Lopez-Pizarro, P Gomez-Herruz, et al.

Nephron|January 1, 1995

Severe renal hypouricemia secondary to hyperbilirubinemiaJ A Arranz-Caso, F J Fernández de Paz, V Barrio, et al.

HIV Medicine|September 15, 2005

A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral loadJ A Arranz Caso, J C López, I Santos, et al.

Pageof 1